Scala Biodesign

BiotechnologySeries ATel Aviv, Israelscala-bio.com

Latest round

Series A

Last raised

Mar 2026

Total raised

$22M

Investors

7

About Scala Biodesign

Based in Israel, Scala Biodesign Ltd.Based in Tel Aviv, Israel, and founded in 2022, Scala Biodesign Ltd. operates as a biotechnology company that develops proteins for pharmaceutical applications. The company was founded by its CEO, Ravit Netzer, and CTO, Adi Goldenzweig and Sarel Fleishman. In March 2026, Scala Biodesign Ltd. Scala Biodesign offers a biotech-based computational platform that uses artificial intelligence (AI) to design proteins for use in medicine, food technology, and industrial applications. The platform’s proteins can be used to create vaccines and enzymes for various therapeutic and industrial manufacturing applications. The firm offers various biological data analyses and one-shot computational solutions.

Who invested in Scala Biodesign

7 investors across 2 rounds

See all investors in Scala Biodesign

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 29, 2026

    Amount

    $16M

    Investors

    Locked

  2. Seed

    Sep 11, 2023

    Amount

    $5.5M

    Investors

    Locked

Questions about Scala Biodesign

Who invested in Scala Biodesign?

Scala Biodesign has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Scala Biodesign raised?

Scala Biodesign has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Scala Biodesign last raise money?

Scala Biodesign's most recent round on record is a Series A, in Mar 2026.

What does Scala Biodesign do?

Based in Israel, Scala Biodesign Ltd.

Where is Scala Biodesign headquartered?

Scala Biodesign is headquartered in Tel Aviv, Israel.

Which VCs invest in companies like Scala Biodesign?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Scala Biodesign's stage. Their profiles are linked below.

Raising like Scala Biodesign? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.